Pulmonary function impairment measured by pulmonary function tests in long-term survivors of childhood cancer
Authors:
- Renée L MulderRMRenée L Mulder
- C. C. E. KoningCKC. C. E. Koning
- H. A. HeijHHH. A. Heij
Open Access
Abstract
Background Childhood cancer survivors (CCSs) have an increased risk of morbidity and mortality. The prevalence and risk factors of pulmonary function impairment were investigated in a large cohort of CCSs treated with potentially pulmotoxic therapy with a minimal follow-up of 5 years after diagnosis. Methods The study cohort consisted of all adult 5-year CCSs who were treated with bleomycin, pulmonary radiotherapy and/or pulmonary surgery in the Emma Children's Hospital/Academic Medical Center between 1966 and 1996. Pulmonary function tests were performed to diagnose obstructive and restrictive pulmonary function impairment, and diffusion capacity impairment. Results The study population consisted of 220 out of 248 eligible CCSs, of whom 193 (87.7%) had performed a pulmonary function test at a median follow-up of 18 years after diagnosis. 85 (44.0%) out of 193 CCSs developed a pulmonary function impairment. Pulmonary function impairments occurred in all treatment groups. Most prevalent were restrictive pulmonary function impairment (17.6%) and a decreased carbon monoxide diffusion capacity (39.9%). Multivariate logistic regression models showed that, compared with bleomycin treatment only, treatment with radiotherapy, radiotherapy combined with bleomycin and radiotherapy combined with surgery were associated with the highest risk of pulmonary function impairment. Conclusions The prevalence of pulmonary function impairment in long-term adult CCSs who received potentially pulmotoxic therapy is high. Bleomycin, pulmonary radiotherapy and pulmonary surgery are all associated with pulmonary function impairment. Pulmonary radiotherapy, especially in combination with bleomycin or surgery, is the most important risk factor. This emphasises the need for adequate counselling and follow-up for this patient population.Keywords
This publication has 18 references indexed in Scilit:
- Pulmonary dysfunction in survivors of childhood hematologic malignancies after allogeneic hematopoietic stem cell transplantationCancer, 2010
- Survival of European children and young adults with cancer diagnosed 1995–2002European Journal of Cancer, 2009
- Medical Assessment of Adverse Health Outcomes in Long-term Survivors of Childhood CancerJAMA, 2007
- Long‐term pulmonary function in survivors of childhood Hodgkin disease and non‐Hodgkin lymphomaPediatric Blood & Cancer, 2007
- Pulmonary function abnormalities in children treated with whole lung irradiationPediatric Blood & Cancer, 2005
- Pulmonary function in long‐term survivors of pediatric hematopoietic cell transplantationPediatric Blood & Cancer, 2005
- Pulmonary function after treatment for acute lymphoblastic leukaemia in childhoodBritish Journal of Cancer, 1998
- Risk factors for reduced pulmonary function after malignant lymphoma in childhoodMedical and Pediatric Oncology, 1998
- Pulmonary function in children treated for rhabdomyosarcomaMedical and Pediatric Oncology, 1996
- A clinical review of bleomycin—a new antineoplastic agentCancer, 1973